Takeda to support Global Fund projects
This article was originally published in Scrip
Takeda has launched a new endowment scheme through which it will contribute a total of around $11 million to various Global Fund projects in Africa.
You may also be interested in...
While disappointing result will probably put an end to single-drug plans in ovarian cancer, the blockbuster anti-PD-1 immunotherapy remains in combination development for the indication.
Japanese firm in discussions with regulator as high-need novel therapy for spinocerebellar degeneration misses endpoint but shows promise in pooled analysis.